Review
doi: 10.1161/HYPERTENSIONAHA.106.075085.
Epub 2007 Apr 23.
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look
Affiliations
- PMID: 17452509
- PMCID: PMC3227117
- DOI: 10.1161/HYPERTENSIONAHA.106.075085
Item in Clipboard
Review
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look
Hypertension.
2007 Jun.
No abstract available
Similar articles
-
[The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].Cardiologia. 1997 Jan;42(1):47-50. Cardiologia. 1997. PMID: 9118154 Review. Italian. No abstract available.
-
Cardiac consequences of aldosterone excess in human hypertension.Am J Hypertens. 2006 Jan;19(1):10-2. doi: 10.1016/j.amjhyper.2005.08.011. Am J Hypertens. 2006. PMID: 16461183 No abstract available.
-
Left ventricular hypertrophy and angiotensin II antagonists.Am J Hypertens. 2001 Feb;14(2):174-82. doi: 10.1016/s0895-7061(00)01257-7. Am J Hypertens. 2001. PMID: 11243310 Review.
-
Role of aldosterone in left ventricular hypertrophy in hypertension.Am J Hypertens. 2006 Jan;19(1):13-8. doi: 10.1016/j.amjhyper.2005.05.013. Am J Hypertens. 2006. PMID: 16461184
-
Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation.Clinics (Sao Paulo). 2010;65(1):85-92. doi: 10.1590/S1807-59322010000100013. Clinics (Sao Paulo). 2010. PMID: 20126350 Free PMC article.
Cited by
-
Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.Hypertension. 2009 Mar;53(3):539-48. doi: 10.1161/HYPERTENSIONAHA.108.120816. Epub 2009 Feb 9. Hypertension. 2009. PMID: 19204184 Free PMC article.
-
Update on tissue renin-angiotensin systems.J Mol Med (Berl). 2008 Jun;86(6):615-21. doi: 10.1007/s00109-008-0336-0. Epub 2008 Apr 15. J Mol Med (Berl). 2008. PMID: 18414822 Review.
-
Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.Exp Biol Med (Maywood). 2020 Apr;245(7):654-666. doi: 10.1177/1535370220908215. Epub 2020 Feb 19. Exp Biol Med (Maywood). 2020. PMID: 32075431 Free PMC article.
-
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.J Clin Invest. 2010 Apr;120(4):1229-39. doi: 10.1172/JCI39345. Epub 2010 Mar 24. J Clin Invest. 2010. PMID: 20335663 Free PMC article.
-
Local angiotensin II aggravates cardiac remodeling in hypertension.Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1328-38. doi: 10.1152/ajpheart.00538.2010. Epub 2010 Sep 10. Am J Physiol Heart Circ Physiol. 2010. PMID: 20833959 Free PMC article.
References
-
- Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–1566. - PubMed
-
- Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl. 2005;23:S27–S33. - PubMed
-
- Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension. 2002;39:744–749. - PubMed
-
- Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Gabiti-Rosei E. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731–738. - PubMed
-
- Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
